Central banks are still holding interest rates high to deal with stubborn inflation in areas like housing and transport, which keeps income focused investors on edge. Reliable cash flows suddenly matter a lot more. That is where the Dividend Powerhouses screener comes in, with stocks offering 3%+ yields that are covered and growing. This article highlights three of the strongest candidates from that list.
The three stocks below are just a starting sample from this idea. The full screen surfaced 28 more companies with income stories that are not covered here. To see the rest and identify which ones best fit your income goals, head straight to the Dividend Powerhouses (3%+ Yield) screener.
CSL (ASX:CSL)
Overview: CSL is a global biopharmaceutical company that collects human plasma and develops medicines and vaccines for serious conditions such as immune deficiencies, bleeding disorders and iron deficiency, alongside influenza vaccines and kidney disease treatments. Its three units, CSL Behring, CSL Seqirus and CSL Vifor, give it a diversified healthcare footprint across rare disease therapies, vaccines and nephrology.
Operations: CSL generates most of its revenue from CSL Behring at about $10.9b, with CSL Vifor contributing about $2.4b and CSL Seqirus about $2.2b.
Market Cap: A$64.4b
CSL may appeal to income investors who want more than just a 3% yield, because behind the dividend sits a global plasma and vaccines business with an established position in rare disease treatments and flu protection. The stock has experienced a period of weaker performance, with profit margins compressed, a large one off loss of $2.1b and a restructuring program funded by high debt, which raises questions about earnings stability and dividend cover. The company is also targeting cost savings and launching new products such as ANDEMBRY in hereditary angioedema to expand its treatment base. For investors assessing the current clean up phase, CSL presents a mix of established assets, near term risks and possible valuation inefficiencies that may warrant further research.
CSL’s clean up phase could be masking a stronger long term income story, with a global plasma and vaccines engine sitting behind today’s compressed margins and restructuring noise. Get the full picture in the analysis report for CSL
Build your own dividend powerhouse shortlist
CSL and the two other stocks in this list came from a single screen, but the real edge for an income portfolio is setting your own rules. Use our flexible Screener to mix filters for dividends, balance sheet strength and risks, or tap into our curated Investing Ideas if you want ready made shortlists.
QBE Insurance Group (ASX:QBE)
Overview: QBE Insurance Group is a global insurer that underwrites a wide mix of general insurance and reinsurance, from home, motor and workers' compensation to marine, energy, aviation and cyber cover, across Australia Pacific, North America and other international markets. It also manages Lloyd's syndicates and runs investment management services, which broadens its income base beyond traditional insurance lines.
Operations: QBE generates about US$11.2b in revenue from International markets, US$8.2b from North America, US$5.7b from Australia Pacific and US$77m from Corporate and other activities.
Market Cap: A$35.7b
QBE Insurance Group stands out in a dividend screen because you are not just getting an insurer tied to one country or product. You are looking at a business with a very strong balance sheet, affirmed A financial strength ratings, and recent earnings growth that has outpaced both Australian insurers and the broader market, alongside a P/E below the global insurance average. At the same time, softening premium rate momentum, catastrophe exposure and an uneven dividend history mean the income story is not straightforward. For investors who can weigh that trade off, the mix of global diversification, cyber and specialty growth potential and value signals may make QBE a candidate for closer consideration within a 3%+ yield portfolio.
QBE’s global reach, strong balance sheet and below average P/E hint at a story where valuation and earnings strength may be decoupling. See the full context in the 3 key rewards and 1 important warning sign
Evolution Mining (ASX:EVN)
Overview: Evolution Mining is an Australian based gold producer that explores for, develops and operates gold and gold copper mines in Australia and Canada, with additional exposure to copper and silver through concentrates. The company sells gold and gold copper concentrates into global markets and has been active since the late 1990s.
Operations: Evolution Mining generates most of its revenue from Cowal at about A$1.7b and Ernest Henry at about A$1.1b, with further contributions from Mungari at about A$780m, Red Lake at about A$670m, Northparkes at about A$580m, and smaller amounts from Mt Rawdon and Corporate activities.
Market Cap: A$27.9b
Evolution Mining gives dividend focused investors something different from the typical income stock. Investors get exposure to gold and copper production with current reported profit margins of 26% and forecast returns on equity above 20%, plus identified growth projects from copper deals such as the Carnaby Resources acquisition and the lithium joint venture in Nevada. However, expectations are already high, the P/E sits above the broader Australian metals and mining industry and the dividend track record is uneven, all against a backdrop of rising costs and ESG obligations. For investors weighing income alongside commodity and battery metals exposure, this mix of quality operations and elevated expectations may warrant closer consideration.
Evolution Mining’s 26% margins and high forecast returns on equity suggest the current P/E premium may not tell the whole story. Get the context in the analyst forecasts for Evolution Mining
Seeking Fresh Alternatives For Your Watchlist?
Some of the most interesting ideas move first, then vanish once the crowd catches on. Scan these fresh stock lists while it matters to review them at an early stage.
- Spot companies with staying power and strong cushions against shocks by checking the curated 10 resilient stocks with low risk scores before that resilience is fully reflected in prices.
- Explore the next stage of automation momentum by shortlisting companies in the 37 robotics and automation stocks while many are still flying under most watchlists.
- Prepare for potential demand shifts by scanning the hand picked 29 elite gold producer stocks before the market focuses on the same producers.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com